Cyclerion Therapeutics, Inc. Balance Sheet
CYCN|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$10M
FY2025
Cash
$3M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$9M
FY2025
Cyclerion Therapeutics, Inc. had $10M in total assets and $9M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.2M | $7.6M | $7.6M | $13.4M | $54.0M | $54.4M | $94.9M |
| Accounts Receivable | $1.0M | $0 | $0 | $96.0K | $100.0K | - | - |
| Current Assets | $4.6M | $8.0M | $8.0M | $14.8M | $55.5M | $58.5M | $101.2M |
| PP&E (Net) | - | $0 | $0 | $0 | $65.0K | $6.9M | $11.6M |
| Total Assets | $10.0M | $13.4M | $13.4M | $18.1M | $59.3M | $115.4M | $186.5M |
| Current Liabilities | $900.0K | $2.1M | $2.1M | $7.6M | $11.1M | $17.0M | $18.2M |
| Shareholders' Equity | $9.1M | $11.3M | $10.5M | $10.5M | $59.5M | $97.7M | -$10.4M |